返回 Agenda
Session Chair(s)
Julienne Vaillancourt, MPH, RPH
Rare Disease Liaison, CBER
FDA, United States
Trent A. Carrier
Chief Business Officer
Biologics Consulting Group, Inc, United States
Panel Discussion
All Session Speakers, United States
Speaker(s)
Clinical Trial Design: A Regulatory Perspective
Jennifer S. Read, MD, MPH, MS
FDA, United States
Medical Officer, Division of Vaccines and Related Products Applications
Case Study: Results of LBP Phase 1 Studies in Healthy Adults
Taha Keilani, MD
Sigma-Tau Pharmaceuticals, Inc, United States
Vice President, Clinical Development
Key Factors for Market Success
Maik Klasen, PHD
Adivo Associates, United States
Managing Director